We are a global frontrunner in making oral vaccines a reality. Weâve created a proprietary Platform Technology using organic plants to manufacture Vaccines and Biologic Drugs. We have proven the Platform Technology through several grants from U.S. National Institutes of Health R&D, by a successful double-blind, placebo-controlled human clinical trial, and by endorsement of the U.S. Food and Drug Administrationâs authorization of a second clinical trial on our very first vaccine. Source
No articles found.
InnaMed is developing a comprehensive care management platform. Our team is develo...
InnaMed is developing a comprehensive care mana...
WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading glo...
WuXi Biologics (stock code: 2269.HK), a Hong Ko...
Nymox Pharmaceutical Corporation specializes in the research and development of th...
Nymox Pharmaceutical Corporation specializes in...
MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiri...
MediciNova, Inc. is a publicly-traded biopharma...
PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage specialty pharmaceutical company i...
PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage...
Omeros is a commercial-stage biopharmaceutical company committed to discovering, d...
Omeros is a commercial-stage biopharmaceutical ...
Altimmune is a clinical-stage immunotherapeutics company focused on the developmen...
Altimmune is a clinical-stage immunotherapeutic...
Join the National Investor Network and get the latest information with your interests in mind.